Author/Creator: Fernandez-Teruel, C. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Fernandez-Teruel, C.

1. 316 Phase I study of lurbinectedin (PM01183) in combination with cisplatin (C) with or without aprepitant (Ap) in patients (pts) with advanced solid tumors. (September 2015)

Authors:: Forster, M.; Sessa, C.; Von Moos, R.; Brown, N.; Metaxas, Y.; Griguolo, G.; Lardelli, P.; Coronado, C.; Juan, L.; Fernandez-Teruel, C.; Soto-Matos, A.; Stathis, A.
Journal:: European journal of cancer
Issue:: Volume 51:(2015)Supplement 3
Page Start:: S60
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Mathematical modeling of oral absorption and bioavailability of a fluoroquinolone after its precipitation in the gastrointestinal tract. (8th January 2013)

Authors:: Fernandez-Teruel, C.; Mangas-Sanjuan, V.; Gonzalez-Alvarez, I.; Ruiz-Garcia, A.; Casabó, V. G.; Bermejo, M.
Journal:: Xenobiotica
Issue:: Volume 43:Number 9(2013:Sep.)
Page Start:: 745
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Phase I study of lurbinectedin (PM01183) in combination with cisplatin (CDDP) with or without aprepitant in patients (pts) with advanced solid tumors. (February 2017)

Authors:: Forster, M.; Sessa, C.; Von Moos, R.; Brown, N.; Metaxas, Y.; Griguolo, G.; Lardelli, P.; Iglesias, J.; Fernandez-Teruel, C.; Jandali, U.; Soto-Matos, S.M.; Stathis, A.
Journal:: European journal of cancer
Issue:: Volume 72(2017)Supplement 1
Page Start:: S134
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗